VS 605
Alternative Names: VS-605Latest Information Update: 29 Jul 2024
At a glance
- Originator Vidasym
- Class Hyperphosphataemia therapies
- Mechanism of Action Phosphate binding modulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Preclinical Hyperphosphataemia